BlackRock Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

BlackRock Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.05M	Sell	83,020 -14,878	-15%	-$277K	﹤0.01%	1838
2016 Q3	$2.74M	Sell	97,898 -2,539	-3%	-$85.2K	﹤0.01%	1351
2016 Q2	$3.52M	Buy	100,437 +56,066	+126%	+$1.76M	﹤0.01%	1244
2016 Q1	$1.22M	Buy	44,371 +28,967	+188%	+$853K	﹤0.01%	1649
2015 Q4	$527K	Sell	15,404 -7,329	-32%	-$229K	﹤0.01%	2054
2015 Q3	$653K	Sell	22,733 -610	-3%	-$26.1K	﹤0.01%	1994
2015 Q2	$1.04M	Buy	23,343 +13,939	+148%	+$524K	﹤0.01%	1630
2015 Q1	$325K	Buy	9,404 +1,592	+20%	+$43.3K	﹤0.01%	2388
2014 Q4	$214K	Buy	+7,812	New	+$190K	﹤0.01%	2586

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock Advisors's DPLO Position: Q4 2016 in Review

BlackRock Advisors reduced its DIPLOMAT PHARMACY, INC. (DPLO) stake by 15% in Q4 2016, selling an estimated $277K and leaving 83,020 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

BlackRock Advisors first reported a position in DPLO in Q4 2014 and has held it in 9 quarters since. The position peaked at $3.52M in Q2 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

BlackRock Advisors held 83,020 shares of DIPLOMAT PHARMACY, INC. worth $1.05M as of Q4 2016.
BlackRock Advisors sold 14,878 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $277K.
DIPLOMAT PHARMACY, INC. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1838 holding.
BlackRock Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and has held it in 9 quarters since.
BlackRock Advisors's DIPLOMAT PHARMACY, INC. position peaked at $3.52M in Q2 2016.
174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.